AIP
NMTR

Ameritas Investment Partners’s 9 Meters Biopharma NMTR Stock Holding History

Ameritas Investment Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-833
Closed -$10K – 3321
2022
Q1 		$10K Hold
833
– – ﹤0.01% 2814
2021
Q4 		$16K Hold
833
– – ﹤0.01% 2751
2021
Q3 		$22K Hold
833
– – ﹤0.01% 2659
2021
Q2 		$18K Buy
+833
New +$20.4K ﹤0.01% 2800
2019
Q2 		– Sell
-73
Closed -$3K – 3134
2019
Q1 		$3K Hold
73
– – ﹤0.01% 2929
2018
Q4 		$3K Hold
73
– – ﹤0.01% 2925
2018
Q3 		$10K Hold
73
– – ﹤0.01% 2838
2018
Q2 		$34K Buy
+73
New +$26.9K ﹤0.01% 2223

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Ameritas Investment Partners's NMTR Position: Q2 2022 in Review

Ameritas Investment Partners sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 833 shares — an estimated $10K sold.

Ameritas Investment Partners first reported a position in NMTR in Q2 2018 and held it in 8 quarters. The position peaked at $34K in Q2 2018. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • Ameritas Investment Partners reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 833 9 Meters Biopharma shares in Q2 2022, an estimated $10K.
  • Ameritas Investment Partners first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 8 quarters.
  • Ameritas Investment Partners's 9 Meters Biopharma position peaked at $34K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.